Skip to main content
Equibles

PRQR · ProQR Therapeutics N.V. · Financials

Track PRQR — free

Use PRQR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRQR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.31 -0.03 (-1.88%)
Rebalance outlook locked
Market Cap
$187.69M
Shares
141.12M
Volume · Oct 23 225.54K Avg daily vol (3M) 799.65K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
15.91M -15.9%
FY2025 Revenue FY2021–FY2025
Net Income
-42.18M -51.9%
FY2025 Net Income FY2015–FY2025
Operating Margin
-273.14% -112pp
FY2025 Operating Margin FY2021–FY2025
Diluted EPS
-0.40 -25%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
-52.79M -45.1%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
EUR 15.91M 18.91M 6.51M 3.59M 1.34M — — — — — —
EUR 44.73M 36.36M 25.15M 50.87M 42.22M 38.14M 46.49M 29.51M 31.15M 31.92M 23.4M
EUR 15.06M 13.66M 16.24M 18.65M 17.37M 13.69M 12.89M 12.54M 10.84M 9.48M 6.84M
EUR 2.7M 2.76M 2.51M 2.52M 2.33M 2.36M 2.05M 992K — — —
EUR -43.45M -30.47M -31.86M -65.16M -57.21M -42.37M -57.45M -36.29M -40.5M -39.57M -27M
EUR 1.29M 1.08M 1.46M 5.13M 3.41M 4.03M 1.08M — — — —
EUR -42.17M -27.96M -27.81M -64.11M -60.68M -46.49M -56.61M -37.09M -43.67M -39.1M -20.83M
EUR -42.18M -27.76M -28.12M -64.42M -60.74M -46.57M -56.48M -36.89M -43.64M -39.1M -20.83M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2026-06-30 EUR 5,017,000 6-K filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current borrowings, including current portion of noncurrent borrowings
EUR 5,017,000
Current lease liabilities 2026-06-30 EUR 1,603,000 6-K filed 2026-08-13
Noncurrent lease liabilities 2026-06-30 EUR 8,692,000 6-K filed 2026-08-13
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1612940 CUSIP N71542109 13F (30d) 7 filings 7 filers Visit website Investor relations